Prostate International
Издатель: Elsevier · ISSN 2287-8882 · 54 статей
- Time for PHOENIX to rest in the ashes: Prostate-specific membrane antigen positron emission tomography guided reassessment of biochemical recurrence after radiotherapy
- Kicking the can down the road: stereotactic body radiotherapy’s role in prolonging systemic treatment efficacy in metastatic castration-resistant prostate cancer
- Efficacy and safety of low-dose red ginseng oil (RXGIN) in men with moderate lower urinary tract symptoms: a randomized, double-blind, placebo-controlled trial
- Integrated clinical and magnetic resonance imaging–based prediction model for pelvic lymph node metastasis in prostate cancer
- Therapeutic potentials of curcumin in prostate cancer: a comprehensive review of pathways and clinical prospects
- Irreversible electroporation in focal therapy for prostate cancer: current status and future directions
- Active surveillance could apply to one-quarter of Korean prostate cancer cases: Insights from a 27,075-patient cohort
- Transrectal ultrasound–cystogram versus X-ray–cystogram versus no cystogram: high volume retrospective study
- Risk stratification for repeat prostate biopsy: PI-RADS 3 lesions and the differential role of PSA density
- Holmium laser enucleation of the prostate versus transurethral resection of the prostate for benign prostatic hyperplasia: evidence from a Korean retrospective analysis using the Common Data Model
- Dissemination of misleading and biased information about benign prostate hyperplasia on YouTube in the Republic of Korea
- Clinical utility of the prostate health index density in patients with negative mpMRI or prior negative biopsy
- Visceral and subcutaneous fat attenuation as prognostic indicators of survival in castration resistant prostate cancer
- A proposal for integrating intraductal carcinoma of the prostate into pathological T substaging
- Asia-Pacific collaborative consensus statements on water vapor thermal therapy (Rezūm) incorporating a systematic review, a two-round Delphi survey, and a consensus meeting
- The accuracy of transperineal template-guided mapping biopsy in patients with negative magnetic resonance imaging
- Omitting biopsy in Prostate Imaging Reporting and Data System 3? The role of Stockholm3 and prostate-specific antigen density findings from a prospective Swiss non-referral cohort
- Seminal vesicle injury during radical prostatectomy does not affect the oncological outcome of prostate cancer patients
- Predictors of false-positive results in men with Prostate Imaging–Reporting and Data System 4 lesions
- Advancing metastatic prostate cancer care: best practices and future directions in molecular testing
- Risk reclassification on follow-up biopsy during active surveillance for prostate cancer: predictors of risk migration
- Value of 68Ga-PSMA PET/CT compared to mpMRI for primary tumor characterization based on radical prostatectomy histopathology
- Comparative assessment of YouTube and TikTok videos as a source of information for minimally invasive benign prostatic obstruction surgical therapies
- Longitudinal comparison of the impact of smoking status on patient-reported sexual function and urinary function following radiotherapy and prostatectomy for localized prostate cancer
- How nations pursued prostate-specific antigen screening policy under restrictive guidelines: an implicit–explicit continuum
- Transurethral resection of prostate prior to radical prostatectomy for prostate cancer: propensity matched analysis of functional outcome from a large volume institution
- The role of three-dimensional printing in prostate cancer: from in vitro modeling to clinical applications
- Comparative oncologic outcomes of high-intensity focused ultrasound versus robotic radical prostatectomy for localized prostate cancer: A propensity-weighted real-world Asian study
- Recorded benign prostatic hyperplasia and subsequent Parkinson disease diagnosis: a nationwide population-based matched cohort study with an exploratory alpha-1 blocker analysis
- Bone health in prostate cancer: two clinical paradigms and the evolving role of bone-protecting agents